Piperidine → HCID 178486246, compound

HRID 736271Notes

Reaction equation

HRID 736271 reaction equation
[NH:1]1[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.Cl[CH2:8][C:9]1[CH:43]=[CH:42][C:12]([C:13]([NH:15][C:16]2[C:17]3[CH:30]=[C:29]([C:31]([NH:33][N:34]([CH3:41])[C:35]4[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=4)=[O:32])[S:28][C:18]=3[N:19](C(OC(C)(C)C)=O)[N:20]=2)=[O:14])=[CH:11][CH:10]=1.ClCC1C=CC(C(NC2C3C=C(C(NN(C4C=CC(Cl)=CC=4)C)=O)SC=3N(C(OC(C)(C)C)=O)N=2)=O)=CC=1>[I-].C([N+](CCCC)(CCCC)CCCC)CCC.CN(C)C=O>[CH3:41][N:34]([C:35]1[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=1)[NH:33][C:31]([C:29]1[S:28][C:18]2[NH:19][N:20]=[C:16]([NH:15][C:13](=[O:14])[C:12]3[CH:42]=[CH:43][C:9]([CH2:8][N:1]4[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]4)=[CH:10][CH:11]=3)[C:17]=2[CH:30]=1)=[O:32]

Participants

6

Reactant 3

HCID 8082PiperidineHCID 57848822HCID 57848822, compoundHCID 57848870HCID 57848870, compound

Product 1

HCID 178486246HCID 178486246, compound

Reagents, catalysts & solvents 2

HCID 67553Tetrabutylammonium IodideCatalystHCID 6228DimethylformamideSolvent

Conditions

Temperature
25 °C

Procedure

27 mg (74 μmol) of tetrabutylammonium iodide and then 110 μL (1.11 mmol) of piperidine are added to a solution of 200 mg (0.37 mmol) of an approximately 70:30 mixture of tert-butyl 3-(4-chloromethylbenzoylamino)-5-(N′-methyl-N′-phenylhydrazinocarbonyl)thieno[2,3-c]pyrazole-1-carboxylate and tert-butyl 3-(4-chloromethylbenzoylamino)-5-(N′-(4-chlorophenyl)-N′-methylhydrazinocarbonyl)-thieno[2,3-c]pyrazole-1-carboxylate in 6 mL of dimethylformamide under argon. The reaction mixture is stirred at a temperature in the region of 25° C. for 16 hours, and then poured onto ice. It is then extracted twice with a 50/50 mixture of ethyl acetate and heptane. The organic extracts are combined, dried over magnesium sulfate and then concentrated to dryness under vacuum (2 kPa) at a temperature in the region of 40° C. The residue is dissolved in 4 mL of methanol and the solution is introduced into a microwave oven tube. The tube is stoppered and the reaction mixture is irradiated at a temperature in the region of 100° C. for 30 minutes. The reaction mixture is then concentrated to dryness under vacuum (2 kPa) at a temperature in the region of 40° C. The residue is purified by preparative LC/MS (conditions B). 75 mg of N-[5-(N′-methyl-N′-phenylhydrazinocarbonyl)-1H-thieno[2,3-c]pyrazol-3-yl]-4-piperidin-1-ylmethylbenzamide are thus obtained in the form of a yellow powder melting from 170 to 182° C. LC-MS-DAD-ELSD: 487(−)=(M−H)(−); 489(+)=(M+H)(+).

Workup

  1. additionpoured onto ice
  2. extractionIt is then extracted twice with a 50/50 mixture of ethyl acetate and heptane
  3. dry with materialdried over magnesium sulfate
  4. concentrationconcentrated to dryness under vacuum (2 kPa) at a temperature in the region of 40° C
  5. dissolutionThe residue is dissolved in 4 mL of methanol
  6. additionthe solution is introduced into a microwave oven tube
  7. customthe reaction mixture is irradiated at a temperature in the region of 100° C. for 30 minutes
  8. concentrationThe reaction mixture is then concentrated to dryness under vacuum (2 kPa) at a temperature in the region of 40° C
  9. customThe residue is purified by preparative LC/MS (conditions B)

Sources & evidence

ORD record
ord-90b63c447dbf49a4abc14ea0297bdcd8
Source dataset
uspto-grants-2009_09
Patent number
US07595320B2

Reaction notes

Loading…